Search Results - "Fichtenbaum, C J"

Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection by FICHTENBAUM, Carl J, GERBER, John G

“…Treatment of HIV infection with potent combination antiretroviral therapy has resulted in major improvement in overall survival, immune function and the…”
Get full text

Genotypic and Phenotypic Characterization of Cryptosporidium parvum Isolates from People with AIDS by Widmer, G., Tzipori, S., Fichtenbaum, C. J., Griffiths, J. K.

“…Genotypic analysis of Cryptosporidium parvum has demonstrated the presence of two subgroups within the species, whereas biochemical and antigenic…”
Get full text

Safety of Discontinuation of Maintenance Therapy for Disseminated Histoplasmosis after Immunologic Response to Antiretroviral Therapy by Goldman, Mitchell, Zackin, Robert, Fichtenbaum, Carl J., Skiest, Daniel J., Koletar, Susan L., Hafner, Richard, Wheat, L. Joseph, Nyangweso, Peter M., Yiannoutsos, Constantin T., Schnizlein-Bick, Carol T., Owens, Susan, Aberg, Judith A.

“…We performed a prospective observational study to assess the safety of stopping maintenance therapy for disseminated histoplasmosis among human…”
Get full text

Tuberculosis and risk of acute myocardial infarction: a propensity score-matched analysis by HUAMAN, M. A., KRYSCIO, R. J., FICHTENBAUM, C. J., HENSON, D., SALT, E., STERLING, T. R., GARVY, B. A.

“…Several pathogens have been associated with increased cardiovascular disease (CVD) risk. Whether this occurs withMycobacterium tuberculosisinfection is…”
Get full text

Osteomyelitis of the Skull in Early-Acquired Syphilis: Evaluation by MR Imaging and CT by Huang, I, Leach, J.L, Fichtenbaum, C.J, Narayan, R.K

“…We present an unusual case of acquired secondary syphilis manifesting as osteomyelitis of the skull in a patient with a history of human immunodeficiency virus…”
Get full text

Ischemic Cardiovascular Disease in Persons with Human Immunodeficiency Virus Infection by David, Max H., Hornung, Richard, Fichtenbaum, Carl J.

“…Persons with human immunodeficiency virus (HIV) infection might be at risk for ischemic cardiovascular disease (CVD). We reviewed the records of 16…”
Get full text

A Randomized Study of the Use of Fluconazole in Continuous versus Episodic Therapy in Patients with Advanced HIV Infection and a History of Oropharyngeal Candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40 by Goldman, Mitchell, Cloud, Gretchen A., Wade, Karen D., Reboli, Annette C., Fichtenbaum, Carl J., Hafner, Richard, Sobel, Jack D., Powderly, William G., Patterson, Thomas F., Wheat, Lawrence J., Stein, David K., Dismukes, William E., Filler, Scott G.

“…Background. In human immunodeficiency virus (HIV)–infected patients, fluconazole prophylaxis is associated with reductions in the rate of fungal infection…”
Get full text

Refractory Mucosal Candidiasis in Patients with Human Immunodeficiency Virus Infection by Fichtenbaum, Carl J., Powderly, William G.

“…Difficult-to-manage mucosal candidal infection has been a hallmark of individuals with advanced infection due to human immunodeficiency virus type 1. In this…”
Get full text

Effect of low-dose IL-2 immunotherapy on frequency and phenotype of regulatory T cells and NK cells in HIV/HCV-coinfected patients by Velilla, P A, Shata, M T, Lages, C S, Ying, J, Fichtenbaum, C J, Chougnet, C

“…We evaluated the effect of low-dose IL-2 therapy (daily 1.2 MIU/m(2), subcutaneously) on the number and phenotype of regulatory T cells (T(regs)) and natural…”
Get more information

Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma by ARRIBAS, J. R, CLIFFORD, D. B, FICHTENBAUM, C. J, ROBERTS, R. L, POWDERLY, W. G, STORCH, G. A

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Refractory Mucosal Candidiasis in Advanced Human Immunodeficiency Virus Infection by Fichtenbaum, Carl J., Koletar, Susan, Yiannoutsos, Constantin, Holland, Fiona, Pottage, John, Cohn, Susan E., Walawander, Ann, Frame, Peter, Feinberg, Judith, Saag, Michael, Van der Horst, Charles, Powderly, William G.

“…We conducted a multicenter, prospective study of the risk factors, natural history, and outcome of fluconazole-refractory mucosal candidiasis (FRMC) in 832…”
Get full text

The Effect of Mode of Administration on Medical Outcomes Study Health Ratings and EuroQol Scores in AIDS by A. W. Wu, D. L. Jacobson, R. A. Berzon, D. A. Revicki, C. van der Horst, C. J. Fichtenbaum, Saag, M. S., L. Lynn, Hardy, D., Feinberg, J.

“…Brief measures of health-related quality of life are being used with increased frequency in AIDS clinical trials. Self-administration of questionnaires can…”
Get full text

Level of Cytomegalovirus (CMV) DNA in Cerebrospinal Fluid of Subjects with AIDS and CMV Infection of the Central Nervous System by Arribas, Jose R., Clifford, David B., Fichtenbaum, Carl J., Commins, Deborah L., Powderly, William G., Storch, Gregory A.

“…The objective of this study was to correlate cytomegalovirus (CMV) DNA levels in the cerebrospinal fluid (CSF) of subjects with AIDS with clinical and…”
Get full text

Progressive Multifocal Leukoencephalopathy in Patients with AIDS Receiving Highly Active Antiretroviral Therapy by Tantisiriwat, Woraphot, Tebas, Pablo, Clifford, David B., Powderly, William G., Fichtenbaum, Carl J.

“…Recent reports suggest that human immunodeficiency virus (HIV)-associated progressive multifocal leukoencephalopathy (PML) may improve with highly active…”
Get full text

Serious Pseudomonas aeruginosa Infections in Patients Infected with Human Immunodeficiency Virus: A Case-Control Study by Fichtenbaum, Carl J., Woeltje, Keith F., Powderly, William G.

“…We conducted a case-control study to determine the incidence and clinical features of and risk factors for Pseudomonas aeruginosa infections in patients…”
Get full text

Immune Reconstitution Syndrome in HIV: Validating a Case Definition and Identifying Clinical Predictors in Persons Initiating Antiretroviral Therapy by Robertson, Jaime, Meier, Matthew, Wall, Jennifer, Ying, Jun, Fichtenbaum, Carl J.

“…Background. Clinical deterioration after initiation of antiretroviral therapy may result from restored immunity. There is no standard clinical definition for…”
Get full text

Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1 by Lennox, J L, Landovitz, R J, Ribaudo, H J, Ofotokun, I, Na, L H, Godfrey, C, Kuritzkes, D R, Sagar, M, Brown, T T, Cohn, S E, McComsey, G A, Aweeka, F, Fichtenbaum, C J, Presti, R M, Koletar, S L, Haas, D W, Patterson, K B, Benson, C A, Baugh, B P, Leavitt, R Y, Rooney, J F, Seekins, D, Currier, J S

Get full text

A Pilot Study of the Management of Uncomplicated Candidemia with a Standardized Protocol of Amphotericin B by Fichtenbaum, Carl J., German, Matthew, Dunagan, W. Claiborne, Fraser, Victoria J., Medoff, Gerald, Diego, Jorge, Powderly, William G.

“…We evaluated an amphotericin treatment strategy on the basis of duration of candidemia and clinical findings. Patients without neutropenia who had…”
Get full text

Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047 by FICHTENBAUM, Carl J, GERBER, John G, ROSENKRANZ, Susan L, SEGAL, Yoninah, ABERG, Judith A, BLASCHKE, Terrence, ALSTON, Beverly, FANG FANG, KOSEL, Bradley, AWEEKA, Francesca

“…Lipid lowering therapy is used increasingly in persons with HIV infection in the absence of safety data or information on drug interactions with antiretroviral…”
Get full text

HIV Protease Inhibitor Induces Fatty Acid and Sterol Biosynthesis in Liver and Adipose Tissues Due to the Accumulation of Activated Sterol Regulatory Element-binding Proteins in the Nucleus by Riddle, Tara M., Kuhel, David G., Woollett, Laura A., Fichtenbaum, Carl J., Hui, David Y.

“…The mechanism by which human immunodeficiency virus (HIV) protease inhibitor therapy adversely induces lipodystrophy and hyperlipidemia has not been defined…”
Get full text